Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study

Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study

Abstract Background It is estimated that around 15–30% of patients with early stage colon cancer benefit from adjuvant chemotherapy. We are currently not capable of upfront selection of patients who benefit from chemotherapy, which indicates the need for additional predictive markers for response to...

Full description

Bibliographic Details
Main Authors: I. van den Berg, S. van de Weerd, J. M. L. Roodhart, G. R. Vink, R. R. J. Coebergh van den Braak, C. R. Jimenez, S. G. Elias, D. van Vliet, M. Koelink, E. Hong, W. M. U. van Grevenstein, M. G. H. van Oijen, R. G. H. Beets-Tan, J. H. J. M. van Krieken, J. N. M. IJzermans, J. P. Medema, M. Koopman, on behalf of the CONNECTION-study group
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Colon cancer
Consensus molecular subtypes
Neoadjuvant chemotherapy
Surgery
Online Access:http://link.springer.com/article/10.1186/s12885-020-07236-y

Internet

http://link.springer.com/article/10.1186/s12885-020-07236-y

Similar Items